Page 9 - கீமோதெரபி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from கீமோதெரபி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In கீமோதெரபி Today - Breaking & Trending Today

Treatment resistance in triple-negative breast cancers linked to softer tissue environment


Treatment resistance in triple-negative breast cancers linked to softer tissue environment
Researchers at the University of California, San Francisco, have discovered that aggressive, triple-negative breast cancers (TNBCs) can evade treatment by reorganizing and softening the collagen matrix that surrounds the cancer cells. The study, which will be published April 2 in the
Journal of Experimental Medicine (
JEM), shows that the softer matrix activates a signaling pathway that promotes the cancer cells survival, and suggests that targeting this pathway could enhance the effectiveness of chemo- and radiotherapy in TNBC patients.
TNBC is an aggressive type of breast cancer with worse survival rates than other forms of the disease. Because TNBC cells lack the HER2 signaling receptor and the estrogen and progesterone hormone receptors, they cannot be eliminated by drugs that specifically target these proteins. Instead, TNBC patients are normally treated with a combina ....

United States , San Francisco , Emily Henderson , University Of California , Department Of Radiation Oncology , Department Of Surgery , Experimental Medicine , Tissue Regeneration , Radiation Oncology , Breast Cancer , Signaling Pathway , ஒன்றுபட்டது மாநிலங்களில் , சான் பிரான்சிஸ்கோ , எமிலி ஹென்டர்சன் , பல்கலைக்கழகம் ஆஃப் கலிஃபோர்னியா , துறை ஆஃப் கதிர்வீச்சு புற்றுநோயியல் , துறை ஆஃப் அறுவை சிகிச்சை , சோதனை மருந்து , திசு மீளுருவாக்கம் , கதிர்வீச்சு புற்றுநோயியல் , மார்பக புற்றுநோய் , சமிக்ஞை நடைபாதை , மன அழுத்தம் , அறுவை சிகிச்சை ,

Study paves way for effective monitoring of chemotherapeutic drug level in cancer patients


Study paves way for effective monitoring of chemotherapeutic drug level in cancer patients
Cancer is the world s second deadliest disease which contributes towards the fatality of over 10 million people per year. Oncologists adopt a variety of treatment procedures to treat cancer cells. Among the different methods used to fight cancer, chemotherapeutic treatment is a prominent and well-adopted technique. It is a drug based method, wherein powerful chemical compounds are injected into the body to annihilate the malignant cells. Although these chemicals support the destruction of the cancerous cells, optimizing their dosage has always been a challenge to the medical specialists. ....

Niigata City , Emily Henderson , Niigata Medical Center , Division Of Gastroenterology , Niigata University , Sciences At Niigata University , Graduate School , Dental Sciences , Uonuma Institute , Community Medicine Niigata University Hospital , Niigata City General Hospital , Saiseikai Niigata Hospital , Kashiwazaki General Hospital , Medical Center , Scientific Reports , Kenya Kamimura , Professor Kenya , Brain Tumor , Breast Cancer , Liver Cancer , Lung Cancer , நீகாட நகரம் , எமிலி ஹென்டர்சன் , நீகாட மருத்துவ மையம் , பிரிவு ஆஃப் இரைப்பை குடல் , நீகாட பல்கலைக்கழகம் ,

Changing diet and exercise can make chemotherapy more effective in youth with leukemia


Changing diet and exercise can make chemotherapy more effective in youth with leukemia
Overweight children and adolescents receiving chemotherapy for treatment of leukemia are less successful battling the disease compared to their lean peers. Now, research conducted at the Cancer and Blood Disease Institute at Children s Hospital Los Angeles indicates that modest changes in diet and exercise can greatly increase survival in youth treated for acute lymphoblastic leukemia (ALL), the most common childhood cancer.
To our knowledge, this is the first study to show that by limiting calories and increasing exercise we can make chemotherapy more effective in eliminating leukemia cells within the first month of therapy, decreasing the chances of disease relapse in children and adolescents. ....

United States , Los Angeles , Deepa Bhojwani , Alan Wayne , Steven Mittelman , Etan Orgel , Emily Henderson , American Society Of Hematology , Blood Disease Institute , Keck School Of Medicine , Jonsson Comprehensive Cancer Center , Supportive Care Service , Hospital Los Angeles , Principal Investigator , Medical Supportive Care Service , Hospital Los , American Society , Keck School , Pediatric Endocrinology , Comprehensive Cancer , Improving Diet , Therapeutic Advances , Childhood Leukemia , Acute Lymphoblastic Leukemia , ஒன்றுபட்டது மாநிலங்களில் , லாஸ் ஏஞ்சல்ஸ் ,

Top 10 Causes of Hair Loss


AskMen
Notifications
You have no notifications
© Getty Images
Genetics Aren t Always to Blame
Shares
The AskMen editorial team thoroughly researches & reviews the best gear, services and staples for life. AskMen may get paid if you click a link in this article and buy a product or service.
Product photos from retailer site.
There is, perhaps, no bigger slap in the face err head for men than when the barber comments about hair loss and thinning. We’ve grown accustomed to associating baldness with aging, despite the fact that this process may be entirely embedded in our DNA and on a timetable we can’t completely control. But before you press your hair follicles against a mirror and stress about their thickness and growth patterns, it’s important to understand and accept a couple things. ....

United States , Bruce Willis , Arash Mostaghimi , Anahad Oconnor , Andrew Surwilo , Alanj Bauman , Dennis Ryan , Jason Statham , American Hair Loss Association , Us National Library Of Medicine , Mental Health America , International Society Of Hair Restoration Surgery , Best Products , American Hair Loss , International Society , Hair Restoration , Hims Complete Hair , Dawn Davis , Aromatherapy Nasal , Shave Your , Pine Tar , Sleep Can Cause Hair , Prospect Farms Dream , Atlantic Coast , Anahado Connor , Top 10 Causes Of Hair Loss ,

Giving chemotherapy in the morning can extend survival of glioblastoma patients


Giving chemotherapy in the morning can extend survival of glioblastoma patients
An aggressive type of brain cancer, glioblastoma has no cure. Patients survive an average of 15 months after diagnosis, with fewer than 10% of patients surviving longer than five years. While researchers are investigating potential new therapies via ongoing clinical trials, a new study from Washington University in St. Louis suggests that a minor adjustment to the current standard treatment -; giving chemotherapy in the morning rather than the evening -; could add a few months to patients survival.
The study appears online in the journal Neuro-Oncology Advances.
Average overall survival for all patients in the study was about 15 months after diagnosis. Those receiving the chemotherapy drug temozolomide in the morning had an average overall survival of about 17 months post diagnosis, compared with an average overall survival of about 13½ months for those taking the drug in the evening, a s ....

Annar Damato , Joshuab Rubin , Jianl Campian , Erikd Herzog , Emily Henderson , School Of Medicine , Siteman Cancer Center Biostatistics Shared Resource , Siteman Cancer Center At Barnes , Division Of Biology Biomedical Sciences , Washington University School Of Medicine , Arts Sciences , Division Of Public Health Sciences , Brain Tumor Center At Siteman , Washington University In St , Washington University , Washington University School , Viktor Hamburger Distinguished Professor , Biomedical Sciences , Public Health Sciences , Siteman Cancer Center , Barnes Jewish Hospital , Brain Tumor Center , Brain Cancer , Neuro Oncology , அன்னார் டமாட்டோ , எமிலி ஹென்டர்சன் ,